Trial Profile
The Effects of Sulforaphane in Patients With Biochemical Recurrence of Prostate Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Sulforafan (Primary)
- Indications Prostate cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 14 Mar 2013 Planned End Date changed from 1 Nov 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
- 07 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Mar 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.